Trending Trauma News:
- Vexim SpineJack and Masterflow registered in Australia for vertebral fracture treatment
- Vertebroplasty trumps placebo in treatment of painful spinal fractures
- First injection of AST-OPC1 stem cells for spinal cord injury takes place in Los Angeles, USA
- AOSPINE North America enrolls 50th patient for spinal cord injury trial
- Fractures That Fail to Heal May Be Predictable Based on Patient Risk Factors
- VEXIM Announces the Registration of Its Products SpineJack® and Masterflow™ For the Treatment of Vertebral Fractures in Australia
- More pain reduction seen in patients with osteoporotic spine fractures after vertebroplasty vs placebo
- Asterias Biotherapeutics Receives Safety Clearance to Begin Administering the Highest Dose of AST-OPC1 in the SCiStar Phase 1/2a Clinical Trial in Cervical Spinal Cord Injury Patients
- Modifiable Factors in Spinal Cord Injury
- Percutaneous pedicle screw fixation plus kyphoplasty for thoracolumbar fractures A2, A3 and B2
Recent Comments